In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Local algae could address Bangladesh’s water crisis
In Bangladesh, scientists from Dhaka University and Sweden’s Uppsala University are using local microalgae to generate clean water.
Pithophora—locally known as Shewla—removes cellulose nanofibers from...
Taiwanese Ghost Festival goes green with biodegradable lanterns
In Taiwan, Xietian Temple will swap polystyrene for banana tree wood in its Ghost Festival floating lanterns.
The environmentally friendly lanterns, shaped like houses with...
Thailand targets top spot in bioplastics
In Thailand, efforts are underway to significantly ramp up bioplastics production using the nation’s significant sugar output as feedstock.
Plastics Institute of Thailand Executive Director...